Dianthus Therapeutics, Inc.: cash_and_restricted_cash
| Value | {"amount": 2663000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Dianthus Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/acd2e0d9-e61c-42bf-9f7a-b78c7d0ab426
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-23-301206 · Open the official SEC filing →Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001690585/cash-and-restricted-cash/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/acd2e0d9-e61c-42bf-9f7a-b78c7d0ab426
History
- supersedes {"amount": 59932000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001193125-21-066707)